<qa>  What is defined as a documented progression within 12 weeks of the last cycle of the first-1. Primary refractory de novo DLBCL or primary refractory follicular grade 3 lymphoma, defined as documented progression within 12 weeks of the last cycle of the first-line multi-agent regimen. 